TBK1 and Other metabolic disease: This work not only elucidates the poorly defined upstream activation of mTORC2 but also improves our understanding of the contribution of TBK1 and mTORCs to physiology and pathologic conditions such as tumorigenesis and obesity-linked metabolic disorders.